Grufity logo
Grufity logo

Latest StemPoint Capital LP Stock Portfolio

$580Million | No. of Holdings #73

StemPoint Capital LP Performance

2026 Q2+15.10%
YTD+17.08%
2025+28.89%

About StemPoint Capital LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, STEMPOINT CAPITAL LP reported an equity portfolio of $580.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of STEMPOINT CAPITAL LP are TNGX, , RVMD. The fund has invested 6.6% of it's portfolio in TANGO THERAPEUTICS INC and 6.5% of portfolio in ABIVAX SA. <br><br> The fund managers got completely rid off SYNDAX PHARMACEUTICALS INC (SNDX), MBX BIOSCIENCES INC and DYNE THERAPEUTICS INC (DYN) stocks. They significantly reduced their stock positions in STRUCTURE THERAPEUTICS INC, PROTAGONIST THERAPEUTICS INC (PTGX) and SCHOLAR ROCK HLDG CORP (SRRK). STEMPOINT CAPITAL LP opened new stock positions in KINIKSA PHARMACEUTICALS INTL, CLIMB BIO INC (ELYM) and INFLARX NV (IFRX). The fund showed a lot of confidence in some stocks as they added substantially to ERASCA INC (ERAS), SPRUCE BIOSCIENCES INC (SPRB) and TANGO THERAPEUTICS INC (TNGX).
StemPoint Capital LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$580Million
  as of Aug 14, 2026

StemPoint Capital LP Annual Return Estimates Vs S&P 500

Our best estimate is that STEMPOINT CAPITAL LP made a return of 15.1% in the last quarter. In trailing 12 months, it's portfolio return was 68.52%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
kiniksa pharmaceuticals intl13,380,500
first tracks biotherapeutics12,529,200
oruka therapeutics inc11,083,600
climb bio inc9,685,400
inflarx nv7,231,290
ovid therapeutics inc6,502,490
equillium inc6,453,140
damora therapeutics inc5,623,210
New stocks bought by StemPoint Capital LP

Additions

Ticker% Inc.
erasca inc226
spruce biosciences inc225
tango therapeutics inc204
tyra biosciences inc63.78
alkermes plc54.06
relmada therapeutics inc22.2
dianthus therapeutics inc17.45
Additions to existing portfolio by StemPoint Capital LP

Reductions

Ticker% Reduced
structure therapeutics inc-90.47
protagonist therapeutics inc-88.77
scholar rock hldg corp-88.45
arcutis biotherapeutics inc-88.04
immunovant inc-81.48
eyepoint inc-79.13
definium therapeutics inc-78.94
newamsterdam pharma company-78.53
StemPoint Capital LP reduced stake in above stock

Sold off

Ticker$ Sold
invivyd inc-4,873,820
syndax pharmaceuticals inc-56,799,500
x4 pharmaceuticals inc-7,027,130
dyne therapeutics inc-18,350,300
mbx biosciences inc-29,818,300
denali therapeutics inc-16,379,900
nurix therapeutics inc-9,772,010
edgewise therapeutics inc-18,324,400
StemPoint Capital LP got rid off the above stocks

Sector Distribution

STEMPOINT CAPITAL LP has about 60.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare60.8
Others39.2

Market Cap. Distribution

STEMPOINT CAPITAL LP has about 8.5% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
Category%
UNALLOCATED39.2
MID-CAP30.4
SMALL-CAP14.5
LARGE-CAP8.5
MICRO-CAP6.4

Stocks belong to which Index?

About 40.6% of the stocks held by STEMPOINT CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others59.4
RUSSELL 200040.6
Top 5 Winners (%)%
QURE
uniqure nv
142.1 %
definium therapeutics inc
90.1 %
CCCC
c4 therapeutics inc
61.2 %
RVMD
revolution medicines inc
59.4 %
maplight therapeutics inc
58.5 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
32.6 M
biohaven ltd
13.7 M
IMVT
immunovant inc
12.1 M
definium therapeutics inc
11.1 M
abivax sa
10.0 M
Top 5 Losers (%)%
VSTA
vistagen therapeutics inc
-52.7 %
TYRA
tyra biosciences inc
-13.8 %
SRZN
surrozen inc
-12.8 %
SPRB
spruce biosciences inc
-12.1 %
CELC
celcuity inc
-7.6 %
Top 5 Losers ($)$
TYRA
tyra biosciences inc
-3.2 M
SRZN
surrozen inc
-2.4 M
CELC
celcuity inc
-1.0 M
TENX
tenax therapeutics inc
-0.3 M
SPRB
spruce biosciences inc
-0.3 M

StemPoint Capital LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of StemPoint Capital LP

STEMPOINT CAPITAL LP has 73 stocks in it's portfolio. About 41% of the portfolio is in top 10 stocks. TYRA proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for STEMPOINT CAPITAL LP last quarter.

$577.91MTotal Value
94.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of StemPoint Capital LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
StemPoint Capital LP's holding in Compass Pathways Plc over time
0.69%284,769
$4.03M
0.69%
new position